New Oral Avastin in macular degeneration Inhibitor Offers Potential Nontoxic Therapy For A Wide
Friday, July 4th, 2008Children’s also is the primary pediatric teaching affiliate of Harvard Medical School. Lucentis and Avastin both block the same protein believed responsible for the blood vessel growth. Fl color promo a img, fl color promo img border noneimportant. In the second study, people receiving Lucentis gained two lines of visual acuity after a year while two lines were typically lost for the patients receiving an Intravitreal kenalog injection treatment a laser activated drug designed to seal off the eye’s abnormal blood vessels responsible for the blindness. Although no volunteers in the second study had vision when tests began, after a year more than percent of Lucentis recipients developed normal vision, regardless of the dose.